INTERNATIONAL PATENT: DRAGONFLY THERAPEUTICS, INC. FILES APPLICATION FOR "ANTI-NKG2D ANTIBODIES AND METHODS OF USE THEREOF"

GENEVA, Dec. 2 -- DRAGONFLY THERAPEUTICS, INC. (180 3rd Avenue, Sixth FloorWaltham, Massachusetts 02451) filed a patent application (PCT/US2025/030438) for "ANTI-NKG2D ANTIBODIES AND METHODS OF USE THEREOF" on May 21, 2025. With publication no. WO/2025/245271, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FALLON, Daniel (c/o Dragonfly Therapeutics, Inc.180 3rd Avenue, Sixth FloorWaltham, Massachusetts 02451), HUANG, Ching-Shin (c/o Dragonfly Therapeutics, Inc.180 3rd Avenue, Sixth FloorWaltham, Massachusetts 02451), JUO...